Clinical Trial

Whey Protein Comparisons for Blood Lipid Effects

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation? Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol. Participants will: * Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-28; most recent amendment 2026-07-12.
Status change: Recruiting → Completed 2026-07-12
Status change: Not Yet Recruiting → Recruiting 2025-08-05
Trial Details
NCT Number NCT07101263
Lead Sponsor Medinutra LLC
Collaborators: Dairy Management Inc.
Conditions Cholesterol
Enrollment 60 participants
Start Date 2025-08-05
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-14